Boosting Research Outcomes Through Innovative Flow Cytometry Integration
Laboratories constantly face the challenge of optimizing workflow efficiency while managing costs. Our partner, a global biopharmaceutical company from Singapore, turned to DKSH to implement Cytek’s full-spectrum flow cytometry technology – streamlining complex processes, reducing costs, and enabling researchers to generate deeper insights with greater speed and precision.
The Cytek Aurora full-spectrum flow cytometer, supplied and supported by DKSH Singapore, enabled our partner to significantly reduce experiment complexity, cost, and processing time compared to traditional cytometry methods. Leveraging DKSH’s deep technical expertise, personalized customer support, and strong business relationship, the company successfully integrated this advanced solution into their existing workflow.

Our partner is a leading global biopharmaceutical company focused on discovering, developing, and providing innovative medicines and vaccines. Their research facility in Singapore specializes in advanced biological research, including immunology, oncology, and infectious diseases, aiming to enhance human health globally.
Challenge
The researchers at our partner’s facility were encountering significant frustrations with their conventional flow cytometry workflow.
Traditional flow cytometers restricted the number of biomarkers that could be analyzed simultaneously due to limitations in dye selection and overlapping emission spectra. As a result, scientists were forced to run multiple separate tubes for each sample, leading to excessive reagent use, increased costs, longer processing times, and a more cumbersome laboratory workflow.
This bottleneck not only slowed down their research progress but also prevented researchers from getting full insights their studies had the potential to deliver.
Approach
Recognizing their operational bottlenecks and the limitations posed by traditional cytometers, DKSH Singapore proposed Cytek’s Aurora full-spectrum flow cytometer as a transformative solution.
To clearly demonstrate its value, DKSH arranged a customized on-site demonstration directly at their research facility, using the researchers’ own samples and experimental protocols. This demo illustrated how the Aurora system simplifies sample preparation by allowing multiple biomarkers to be analyzed simultaneously in a single tube, even with dyes that closely overlap in emission wavelengths.
The DKSH team also conducted a detailed cost-benefit analysis to show tangible savings in reagent usage, operational efficiency, and overall laboratory productivity.
Additionally, understanding the concerns around adopting new technology, DKSH took proactive steps to minimize disruption and ease the transition process. DKSH provided tailored, hands-on training sessions specifically designed around our partner’s existing laboratory protocols and workflows, significantly reducing the learning curve.
DKSH’s dedicated service team also provided comprehensive ongoing support, ensuring a seamless transition and immediate integration of the new technology into their existing research processes.
Result
With the integration of the Cytek Aurora flow cytometer, our partner experienced immediate and substantial improvements in their laboratory efficiency and research productivity. They significantly reduced both reagent costs and sample preparation time by consolidating multiple tests into a single streamlined workflow. Researchers quickly adapted to the new technology, remarking positively about its intuitive design and ease of use, which minimized disruptions and allowed rapid adoption within the team.
The Aurora’s ability to analyze multiple biomarkers simultaneously not only improved throughput but also provided richer, more precise data, enabling deeper scientific insights and accelerating research cycles. This positive experience has strengthened our longstanding partnership, with our partner already planning future expansions to include Cytek’s additional modules such as Enhanced Small Particle Detection, further showcasing their confidence in the value delivered by both the technology and DKSH’s comprehensive support.




